News and updates — Page 2 of 24 — German Market Access

Navigating the New 20% Discount Rule for Combination Drugs: What You Need to Know

The healthcare sector in Germany continues to evolve as the government introduces new measures aimed at controlling costs while maintaining access to

Here are the latest G-BA decisions from the G-BA meeting held on 2 Oct 2024 on the early benefit assessments of Velsipity,

Here are the latest G-BA decisions from the G-BA meeting held on 19 Sep 2024 on the early benefit assessments of Skyclaris,

Here are the latest G-BA decisions from the G-BA meeting held on 15 Aug 2024 on the early benefit assessments of Rystiggo,

Here are the latest G-BA decisions from the G-BA meeting held on 1 Aug 2024 on the early benefit assessments of Rezzayo,